TScan Therapeutics Inc.

NASDAQ: TCRX · Real-Time Price · USD
1.70
-0.08 (-4.49%)
At close: Jun 05, 2025, 12:46 PM

TScan Therapeutics Revenue

TScan Therapeutics reported an annual revenue of $2.82M, reflecting a -86.62% growth. For the quarter ending March 31, 2025, TScan Therapeutics generated $2.17M in revenue.
Revenue (ttm)
$2.82M
Revenue Growth
-86.62%
Price / Sales Ratio
120.9
Revenue / Employee
$14.08K
Employees
200
Market Cap
96.2M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.